We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

NewLink Announces Clinical Development Milestone Achieved with Merck

News   Feb 26, 2015

 
NewLink Announces Clinical Development Milestone Achieved with Merck
 
 
 

RELATED ARTICLES

Revealed: How Deadly Pneumococcus Suppresses Immune Defenses

News

Scientists have discovered a new and important function of a toxin produced by disease-causing bacteria that could have significant implications for future vaccine design.

READ MORE

Drug Reduces Menstrual Bleeding for Women with Gynecologic Tumors

News

A new oral drug significantly reduced menstrual bleeding for women with the most common gynecologic tumors in the United States - benign tumors that disproportionately affect African-Americans, an international clinical trial found.

READ MORE


 

Like what you just read? You can find similar content on the communities below.

Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE